BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for Genocea Biosciences, Inc. (GNCA)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Genocea Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-11
7:54 pm
Purchase		 2021-12-31 13G Genocea Biosciences, Inc.
GNCA		 BIOTECHNOLOGY VALUE FUND L P 5,930,353
9.990%		 644,804increase
(+12.20%)		 Filing
2021-02-12
5:03 pm
Purchase		 2020-12-31 13G Genocea Biosciences, Inc.
GNCA		 BIOTECHNOLOGY VALUE FUND L P 5,285,549
9.990%		 2,123,881increase
(+67.18%)		 Filing